Agency Information Collection Activities; Announcement of OMB Approval; Postmarketing Studies for Approved Human Drug and Licensed Biological Products; Status Reports

摘要

The Food and Drug Administration (FDA) is announcing that a collection of information entitled "Postmarketing Studies for Approved Human Drug and Licensed Biological Products; Status Reports" has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995.